[Therapy of asthenoneurotic syndrome in patients with focal muscular dystonia].
AIM
To analyze the prevalence and structure of asthenoneurotic disorders in patients with focal muscular dystonia and determine an effect of the anxiolytic Ð°daptol (tetramethyltetraazabicyclooctandion) on asthenic syndrome in muscular dystonia.  MATERIAL AND METHODS
Forty patients with focal muscular dystonia were examined.
The severity of asthenic syndrome (MFI-20), anxiety (the Hospital scale of anxiety and depression) and depression (the Hamilton Depression Rating Scale) were evaluated.  RESULTS AND CONCLUSION
Asthenic syndrome and anxiety disorder are independent non-motor manifestations of focal muscular dystonia.  Adaptol has a positive effect, significantly reducing anxiety and asthenia in patients with focal muscular dystonia.
